FRANKFURT (Dow Jones) – Celesio AG has its EBITDA target for 2009 confirmed. "Figures we deliver the Annual Report in March. But I can say so much that we in our get published views, an EBITDA of EUR 625 million to want to hold on to. And 2015, we want an EBITDA of more than EUR 1 billion generate, "said Fritz Oesterle, CEO of the Stuttgart Pharmaceutical distributor, told the "Handelsblatt" (Monday Edition) on the question of how the past year for the company was gone.
To buy the brand Doc Morris Oesterle said that this was the Doc Morris was the right decision and play in the Expansion strategy, a significant role. "The Doc-Morris-brand partnership should be suitable for countries where we do not own Allowed to operate pharmacies, "said Oesterle further.
When asked whether it will stay with the target, 2015 around 500 To want to have partnerships Doc Morris, Chief Executive Officer: "Yes, but the goal is only valid for Germany. As others have Countries not yet included. In Ireland we’re at it, Doc Morris as a brand for our own pharmacies to build and see also the possibility of Doc Morris as a mark for Franchise pharmacies to take. "
When asked how many Doc Morris pharmacies in Europe Celesio estimates and 2015 may operate, Oesterle said: "Today, a number call would be frivolous. It is clear, in any case be more than 500 ". The MDAX-listed group Celesio 2007, approximately 90% of the Pharmacies brands Doc Morris bought what many German pharmacies with a boycott the wholesale subsidiary Go receipted.
Website: www.handelsblatt.de DJG / cbr / brb Visit our website http://www.dowjones.de
(END) Dow Jones Newswires
February 22, 2010 01:56 ET (06:56 GMT)
Copyright (c) 2010 Dow Jones & Company, Inc.